Moors & Cabot’s Oracle ORCL Stock Holding History

Moors & Cabot’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Hold	–	-$3.6K	–	868
2023 Q2	–	Hold	–	–	–	831
2023 Q1	–	Hold	–	–	–	852

Other funds holding ORCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Moors & Cabot's ORCL Position: Q2 2026 in Review

Moors & Cabot reduced its Oracle (ORCL) stake by 11% in Q2 2026, selling an estimated $881K and leaving 40,597 shares worth $5.95M. The position accounts for 0.23% of the portfolio, ranked #87.

Moors & Cabot first reported a position in ORCL in Q1 2014 and has held it in 50 quarters since. The position peaked at $10.4M in Q3 2025. 3,528 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

Moors & Cabot held 40,597 shares of Oracle worth $5.95M as of Q2 2026.
Moors & Cabot sold 4,862 Oracle shares in Q2 2026, an estimated $881K.
Oracle made up 0.23% of Moors & Cabot's portfolio in Q2 2026, its #87 holding.
Moors & Cabot first reported a position in Oracle in Q1 2014 and has held it in 50 quarters since.
Moors & Cabot's Oracle position peaked at $10.4M in Q3 2025.
3,528 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.